Supplementary Figure 3 from Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 3. Graph showing growth of xenografted MKN28 gastric tumors following treatment with paclitaxel alone or in combination with RG7787 over a 60 day time course.
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362622252
